Why the study?
Target tissue concentrations correlate with effect and may be influenced by the number of administrations, but the impact of repeated bolus versus continuous infusion remained unclear.
Does continuous infusion of doxorubicin alter plasma and tissue concentrations compared to bolus infusion in a tumour-free porcine model?
Does continuous infusion of doxorubicin alter plasma and tissue concentrations compared to bolus infusion in a tumour-free porcine model?
Continuous and bolus infusions of doxorubicin result in similar, low tissue concentrations in a porcine model, suggesting similar expected anti-neoplastic efficacy at the tissue level.
Answers are grounded in this paper and cite their sources.
Animal data leave open whether infusion method affects doxorubicin efficacy in patients; no practice change warranted.
PURPOSE: The aim of this study was to evaluate plasma and bone- and soft-tissue concentrations of doxorubicin following two administrations of either bolus or continuous infusion administered at a three-week interval. The achievement of adequate concentration at target sites is believed to be positively correlated to effect, and it has been suggested that concentrations are affected by the number of administrations. METHODS: Eighteen female pigs were included in the study and randomized into two groups of nine receiving either a bolus or continuous infusion. The animals received a dosage of 2 mg/kg on day 1 and on day 22. From day 1 to 10, doxorubicin concentrations, as well as kidney and liver function, were monitored with plasma samples (total concentrations). On day 22, doxorubicin was measured in plasma samples (total concentration) and microdialysates (unbound concentrations) from subcutaneous tissue, muscle, synovial fluid of the knee joint, cancellous bone, and intravenously. Bone- and soft tissue concentrations were below 0.10 µg/mL. Except for mean plasma (total) concentration at the 6 h timepoint on day 1 and 22 in the continuous group, which was higher after the first administration (p = 0.037), no differences in plasma concentrations were found between the two administrations. CONCLUSION: Low mean tissue doxorubicin concentrations and similar pharmacokinetic profiles were found between the bolus and continuous infusion groups. Thus, similar anti-neoplastic efficacy is to be expected with both administration types.
No takes yet. Share an insight, caveat, or question.
Jørgensen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: